Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment

DOI: 10.1007/s00262-025-03994-5 Publication Date: 2025-03-07T10:43:11Z